🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Adaptive Stereotactic Radiotherapy for Localized Prostate Cancer

RecruitingNAAges 60 Years - anyMaleClinique Sainte Clotilde
NCT07344844 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study evaluates whether adaptive stereotactic body radiotherapy (SBRT) provides dosimetric advantages compared to non-adaptive SBRT in localized prostate cancer. Five low-dose CT scans are performed before each SBRT session to assess anatomical variations (bladder filling, rectal volume) and determine if a dosimetric recalculation would have been required. The study also evaluates cumulative dose to organs at risk, patient-reported quality of life over 24 months, and overall and recurrence-free survival.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Male aged ≥60 years * Localized prostate cancer of low or intermediate risk (T1-T2) * Gleason score 6-7 * PSA \<15 ng/mL * No evidence of metastatic disease * Radiotherapy indicated for prostate cancer * Affiliated with or benefiting from a French social security system * French-speaking patient * Patient appropriately informed and having signed a written informed consent form Exclusion Criteria: * Unable to read, write, or understand French * Vulnerable patient as defined by Article L1121-6 of the French Public Health Code * Adult under guardianship, curatorship, or legal protection ("sauvegarde de justice") * Patient unable to personally provide informed consent according to Article L1121-8 of the French Public Health Code * Patient already included in another interventional study that could interfere with study outcomes * History of urological (prostate) or digestive surgery that could influence study outcomes * Refusal to sign the written informed consent form
💊

What it tests

  • Low-dose CT imaging before each SBRT session
📍

Where

1 site
Clinique Sainte Clotilde
Saint-Denis, Reunion
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy